Skip to content

Alli Antar

  • Ph.D.
  • Instructor
  • Baylor College of Medicine
  • 9h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 274CitationsNumber of citations received by Alli's publications. Updated daily.


Alli Antar graduated from with a Ph.D. in Molecular Physiology and Biophysics from Vanderbilt University in 2007. In graduate school, with funding support from the National Institutes of Health as well as the Lupus Foundation of America, Dr. Antar's project focused on the role of the enzyme 11beta-hydroxysteroid dehydrogenase type 1 in modulating lipid metabolism, as well as on its expression in and potential impact on the development of thymocytes. Since then, the chief goal of Dr. Antar's research has been to elucidate the mechanisms whereby various proteins impact metabolism and immune cell function in adipose tissue. As a postdoctoral fellow, she received support from awards that she won from the National Institutes of Health as well as a fellowship from the American Heart Association. Alli Antar is currently continuing her research at Baylor College of Medicine and is actively involved in scientific societies that are both general in scope and specific to her field. In addition to her research, Dr. Antar enjoys supervising and training students in the lab, as well as reviewing manuscripts for several journals in her area of scientific specialization.

Recent publications

  • FABP4-cre mediated expression of constitutively active ChREBP protects against obesity, fatty liver, and insulin resistance

    • Nuotio-Antar A
    • Poungvarin N
    • Li M
    • et al.
    Get full text
  • The glucose sensor ChREBP links de novo lipogenesis to PPARγactivity and adipocyte differentiation

    • Witte N
    • Muenzner M
    • Rietscher J
    • et al.
    Get full text

Professional experience


Baylor College of Medicine

July 2012 - Present

Co-authors (57)

Other IDs